Skip to main content
. 2020 Mar 24;3(3):e201541. doi: 10.1001/jamanetworkopen.2020.1541

Figure 2. Age-Dependent Reduction in Risk for All Neurodegenerative Diseases (NDDs) and Alzheimer Disease (AD) Associated With Hormone-Modulating Therapy (HMT) Exposure.

Figure 2.

A significantly decreased risk of diagnosis of both overall NDDs and, more specifically, AD was observed for patients treated with HMT vs those not treated with HMT.